Dronedaron (Multaq) a cieżkie uszkodzenie wątroby

Prośba do kolegów kardiologów. Mój lekarz zlecił mi od kilku tygodni Multaq. Artykuł z dzisiejszego Medscape, który cytuje poniżej, troche mnie wystraszył. Czy macie jakies obserwacje w tym zakresie, jakieś sugestie? Dzieki. Dronedarone Linked to Severe Liver Injury Medscape - http://www.medscape.com/viewarticle/735804 January 4, 2011 (Silver Spring, Maryland) — Sanofi-Aventis has sent US healthcare professionals a letter warning them about cases of rare but severe hepatic injury associated with use of the antiarrhythmic drug dronedarone (Multaq), the company has informed heartwire . In two instances, liver transplants had to be performed. The FDA has also issued a "safety communication" [1]. The Sanofi letter describes the possibility of liver-function-test abnormalities and hepatocellular injury in patients taking the product, but the company is stressing that no causal association between the d